ACLP-Logo

Advancing Integrated Psychiatric Care
for the Medically Ill

Member Portal

Our website is undergoing maintenance.

References

Clinical Monograph: Aggression & Violence

REFERENCES

  1. Coccaro EF, Berman ME, Kavoussi RJ. Assessment of life history of aggression: development and psychometric characteristics. Psychiatric Research. 1997;73(3):147- 157.
  2. Krug EG, Dahlberg LL,  Mercy JA et al. World report on violence and health.  World Health Organization. Geneva. 2002.
  3. US Center for Disease Control. http://www.cdc.gov/ViolencePrevention/overview/index.html
  4. Hoyert DL, Xu J. Deaths, Preliminary Data for 2011. National Vital Statistics Report.  Centers for Disease Control. 2012;61(6):1-52.
  5. Kansagra SM, Rao SR, Sullivan AF et al. A Survey of workplace violence Across 65 US emergency departments. Academic Emergency Medicine. 2008. 15(12):1268 -72.
  6. Hahn S, Hantikainen V, Needham I et al. Patient and visitor violence in the general hospital, occurrence, staff interventions and consequences. Journal of AdvancedNursing 2012;68(12):2685-99. accessed 5-28-2012.
  7. Swanson JW, Holtzer CE, Ganju VK et al. Violence and psychiatric disorder in the community: Evidence from the Epidemiological Catchment Area surveys. Hospital and Community Psychiatry. 199041:761-770.
  8. Elbogen EB, Johnson SC. The intricate link between violence and related conditions. Archives of General Psychiatry.2009. 66(2):152-160.
  9. Sheridan M, Henrion R, Robinson L et al. Precipitants of violence in a psychiatric inpatient setting. Hospital and Community Psychiatry 1990;41(7):776-80.
  10. Barlow K, Grenyer B, Ilkiw-Lavalle. Prevalence and precipitants of aggression in psychiatric inpatient units. Australian and New Zealand Journal of Psychiatry. 2000;34(6):967-974.
  11. Junginger J, McGuire L. Psychotic motivation and the paradox of current research on serious mental illness and rates of violence. Schizophrenia Bulletin 2004;30(1):21-30.
  12. McNiel DE, Eisner JP, Binder RL. The Relationship Between command hallucinations and violence. Psychiatric Services. 2000;51:1288-1292.
  13. Swanson JW, Swartz MS, Van Dorn RA et al. A national study of violent behavior in persons with schizophrenia. Archives of General Psychiatry. 2006. 63:490-499.
  14. Fazel S, Gulati G, Linsell L et al. Schizophrenia and violence: systematic review and meta-analysis. PLoS Medicine. 2009. 6(8): http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2F journal.pmed.1000120
  15. Soyka M, Graz C, Bottlender R. et al. Clinical correlates of later violence and  criminal offenses in schizophrenia. Schizophrenia Research. 2007.94:89-98.
  16. Ballister J, Goldstein T, Obreja M et al. Is bipolar disorder specifically associated with  aggression? Bipolar Disorder 2012;14(3):283-90.
  17. Fazel S, Lichtenstein P, Grann M. Bipolar disorder and violent Crime. Archives of General Psychiatry. 2010. 67(9):932-938.
  18. Reid WH, Thorne SA. Personality disorders and violent potential. Journal of Psychiatric Practice. 2007.;13(4):261-268.
  19. Fountoulakis KN, Leucht S, Kaprinis GS. Personality disorders and violence. CurrentOpinion in Psychiatry. 2008;21:84-92.
  20. Diagnostic and Statistical Manual, Fourth Edition, Text Revision. (DSM-IVTR).American Psychiatric Association. Arlington, Va. 2000.
  21. Allen A, Links PS. Aggression in borderline personality disorder: Evidence for Increased Risk and Clinical Predictors. Current Psychiatry Reports. 2012.
  22. Coccaro EF. Intermittent Explosive Disorder: development of integrated research criteria for Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Comprehensive Psychiatry.2011;52:119-125.
  23. Kessler RC, Caccaro EF, Fava M. The Prevalence and correlates of DSM-IV, intermittent explosive disorder in the National Comorbidity Survey Replication. Archives of General Psychiatry. 2006;63(6):669-678.
  24. Cherpitel CJ. Alcohol and injuries: a review of international emergency room studies since 1995. Drug and Alcohol Review. 2007. 26:201-214.
  25. Roche AM, Freeman T, Skinner N. From data to evidence, to action: Findings from a systematic review of hospital screening studies for high-risk alcohol consumption. Drug and Alcohol Dependence. 2006;83:1-14.
  26. Roizen, J. Epidemiological issues in alcohol-related violence. In: Galanter, M., ed.  Recent Developments in Alcoholism.1997;Vol. 13. New York: Plenum Press7-40.  
  27. Hoaken PN, Stewart SH. Drugs of abuse and the elicitation of human aggressive behavior. Addictive Behaviors. 2003;28:1533-1554.
  28. Dawe S, Davis P, Lapworth et al. Mechanisms underlying aggressive and hostile behaviour in amphetamine users. Current Opinion in Psychiatry. 2009;  22:268-273.
  29. Payer DE, Lieberman MD, London ED. Neural correlates of affect processing and  aggression in methamphetamine dependence. Archives of General Psychiatry. 2011;68(3):271-282.
  30. Rouve N, Bagheri H, Telmon N et al. Prescribed drugs and violence: a case/non-case study in the French PharmacoVigilance Database. European Journal of Pharmacology. 2011;67:1189-1198.
  31. Kanayama G, Hudson JI, Pope HG. Long term psychiatric and medical consequences of anabolic-androgenic steroid abuse. Drug and Alcohol Dependence 2008;98(12):1-12.
  32. Trenton AJ, Currier GW. Behavioral manifestations of anabolic steroid use. CNS  Drugs.2005;19(7):571-595.
  33. Benson BA, Brooks WT. Aggressive challenging behavior and intellectual disability. Current Opinion in Psychiatry 2008;21:454-458.
  34. Brylewski J, Duggan L. Antipsychotic medication for challenging behavior in people  with learning disabilities (Review). Cochrane Database of Systematic Reviews. 2004  Issue 3:1-32.
  35. Onyike, C, Lyketsos CG. Aggression and Violence. Textbook of Psychosomatic  Medicine. American Psychiatric Publishing Inc. Washington/London. 2010.
  36. Susan A, Ropacki, Dilip V. Jeste. Epidemiology of and risk factors for psychosis of  Alzheimer’s Disease: A Review of 55 studies published from 1990 to 2003. American  Journal of Psychiatry 2005;162:2022-2030.
  37. Somaia M, Rosenheck R, Lyketsos, CG. Effect of second generation antipsychotics on caregiver burden in Alzheimer’s Disease.  Journal of Clinical Psychiatry. 2012;73(1):121-128.
  38. Brower MC, Price BH. Neuropsychiatry of frontal lobe dysfunction in violent and criminal behavior. Journal of Neurology, Neurosurgery and Psychiatry. 2001;71:720-  726.
  39. Rao V, Rosenburg P, Bertrand M et al. Aggression after traumatic brain injury: Prevalence and Correlates. Journal of Neuropsychiatry and Clinical Neuroscience. 2009;21(4):420-429.
  40. Demarree HA, Harrison DW. Case study: topographical brain mapping in hostility  following mild closed head injury. International Journal of Neuroscience. 1996;87  (1-2):97-101.
  41. Tonkonogy JM, Geller JL. Hypothalamic lesions and intermittent explosive disorder. Journal of Neuropsychiatry and Clinical Neuroscience. 1992;4(1);45-50.
  42. Delgado-Escueta AV, Mattson RH, King L et al. The nature of aggression during epileptic seizures. New England Journal of Medicine. 1981;305:711-716.
  43. Knox DK, Holloman GH. Use and avoidance of seclusion and restraint: consensus statement of the American Association of Emergency Psychiatry, “Project BETA”. Seclusion and Restraint Work Group. Western Journal of Emergency Medicine.  2012;13(1):35-40.
  44. Ferrier N, Piling S, Bazire S. Bipolar Disorder, the management of bipolar disorder in adults, children and adolescents in primary care. National Clinical Practice Guideline  number 38.2006. http://www.nice.org.uk/nicemedia/pdf/CG38fullguideline.pdf.  accessed 5-28-2012.
  45. Lehman AF, Liebermen JA, Dixon LB et al. Practice guideline for the treatment of Patients with Schizophrenia, 2nd edition. American Journal of  Psychiatry.2004;161(2):1-56.
  46. MacDonnald K, Wilson MP, Minassian A et al. A retrospective analysis of intramuscular haloperidol and olanzapine in  the treatment of agitation in drug and alcohol using patients. General Hospital Psychiatry 2010;32:443-445.
  47. Huf G, Alexander J,Allan MH et al. Haldol plus promethazine for psychosis-induced aggression. Cochrane Database of Systematic Reviews. 2011,11.
  48. Hassaballa HA, Balk RA. Torsade de Pointes associated with the administration of intravenous Haldol. American Journal of Therapeutics. 2003;10(1):58-60.
  49. Citrome L. Comparison of intramuscular ziprasidone, olanzapine or aripiperazole: a quantitative review of efficacy and safety. Journal of Clinical Psychiatry. 2007;68:1876-1885.
  50. Marder SR. A review of agitation in mental illness: treatment guidelines and current therapies. Journal of Clinical Psychiatry. 2006;(suppl 10):13-21.
  1. Battaglia J, Rush J et al. Haloperidol, lorazepam, or both for psychotic agitation: a  multicenter, prospective, double-blind, emergency department study. 1997;15:335-340.
  2. Schatzberg AF, Cole JO, DeBattista C. Manual of Clinical Pharmacology 7th ed.  Washington, DC American Psychiatric Publishings, Inc. 2010
  3. Swanson JW, Schwartz MS, Van Dorn RA. Comparison of antipsychotic medication  effects in reducing violence in people with schizophrenia. British Journal of Psychiatry. 2008;193(1):37-43.
  4. Volavka J, Czobor P, Derks EM. Efficacy of antipsychotic drugs against hostility in the  European First-Episode Schizophrenia Trial (EUFEST). Journal of Clinical Psychiatry. 2011;72(7);955-61.
  5. Buckley PF, Paulsson B, Brecher M. Treatment of agitation and aggression in bipolar  mania: efficacy of quitiapine. Journal of Affective Disorders.2007;100:S33-43.
  6. Latalova K, Prasco J. Aggression in borderline personality disorder. Psychiatric Quarterly. 2010;81:239-251.
  7. Tsiouris JA. Pharmacotherapy for aggressive behavior in persons with intellectual disabilities: treatment or mistreatment? Journal of Intellectual Disabilty Research.  2010;54(1):1-16.
  8. Ratey J, Sovner R, Parks A et al. Buspirone treatment of aggression and anxiety in  mentally retarded patients. Journal of Clinical Psychiatry. 1991;52(4) :159-62.
  9. Coccaro, EF, Lee RJ, Kavoussi RJ. A Double blind, placebo controlled trial of  Fluoxetine in patients with intermittent explosive disorder. Journal of Clinical Psychiatry. 2009;70(5):653-662.
  10. Jones RM, Arlidge J, Gillham R et al. Efficacy of mood stabilizers in the treatment of impulsive or repetitive aggression: a systematic review and meta-analysis. British Journal of Psychiatry. 2011;198;93-98.
  11. Leentjens A.F.G., Rundell J, Rummans T et al. Delirium: An evidence-based  monograph for psychosomatic medicine practice. Published jointly by Academy of  Psychosomatic Medicine and European Association for Psychosomatic Medicine. 2012;  Journal of Psychosomatic Research2012;73(2):49-51.
  12. Sink KM, Holden KF, Yaffe K. Phamacological treatment of neuropsychiatric symptoms of dementia - A review of the evidence. Journal of American Medical  Association 2005; 293(5):596-608.
  13. Scneider L, Tariot PN, Dagerman KS et al. Effectiveness of atypical antipsychotic drugs in patients with Alzheimer’s Disease. New England Journal of Medicine  2006; 355(15):1525-1538.
  14. Sultzer DL, Davis SM, Tariot PN et al. Clinical symptom responses to atypical  antipsychotic medications in Alzheimer’s Disease Phase 1 Outcomes from the CATIE-AD Effectiveness Trial. American Journal of Psychiatry 2008; 165(7):1-21.
  15. Huybrechts KF, Gerhard T, Crystal S et al. Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: population-based cohort study.  British Journal of Medicine 2012; 344:e977.
  16. Devanand DP, Mintzer MD, Schultz SK et al. Relapse risk after discontinuation of risperidone in Alzheimer’s Disease. New England Journal of Medicine 2012; 367(16):1497-1506.
  17. Herrman N, Li A, Lanctot K. Mementine in Dementia: a review of the current evidence. Expert Opinion, Pharamcotherapeutics 2011; 12(5):787-800.
  18. Levy M, Berson A, Cook T. Treatment of agitation following traumatic brain injury: A  review of the literature. Neurorehabilitation 2005; 20:279-306.
  19. Fleminger S, Greenwood RRJ, Oliver DL. Pharmacological management for agitation and Aggression in People with acquired brain injury. Cochrane Database of Systematic Reviews 2008; 4:1-25.
  20. Kim E, Bijlani M. A pilot study of quetiapine treatment of aggression due to traumatic brain injury. Journal of Neuropsychiatry and Clinical Neuroscience 2007; 18(4):547-549.
  21. Chew E, Zafonte RD. Pharmacological management of neurobehavioral disorders following traumatic brain injury - a state of the art review. Journal of RehabilitationResearch and Development 2009; 46(6):851-878.
  22. Silver, JM, Yudofsky SC, Slater JA et al. Propranolol treatment of chronically  hospitalized aggressive patients. Journal of Neuropsychiatry and Clinical Neuroscience  1999; 11(3):328-335.